Montai Therapeutics Appoints Allison Bogosian, JD, as Chief People and Administrative Officer
Montai Therapeutics, a company harnessing AI to decode untapped, diverse chemistry to develop breakthrough medicines for chronic disease, today announced the appointment of Allison Bogosian, JD, as Chief People and Administrative Officer.
Montai Therapeutics Appoints Renowned Chemical Innovator Larry Hamann to Company’s Board of Directors, Convenes Multidisciplinary Scientific Advisory Board to Inform Strategic Momentum
Montai Therapeutics, a company pioneering at the intersection of AI, diverse human chemistry and validated biology to discover breakthrough small molecules for chronic disease, is expanding its network of renowned scientific and technical advisors with the appointment of Larry Hamann to its Board of Directors and the launch of the company’s Scientific Advisory Board (SAB).
